Medicine & Life Sciences
Drug Discovery
100%
Structure-Activity Relationship
56%
Cyclic GMP-Dependent Protein Kinases
47%
Phosphodiesterase 5 Inhibitors
46%
epigallocatechin gallate
45%
Pharmaceutical Chemistry
45%
Diamines
41%
Organic Chemistry
41%
Serotonin Uptake Inhibitors
39%
Plasmodium falciparum
37%
staurosporine aglycone
35%
Brugia malayi
33%
Phosphoric Diester Hydrolases
32%
Pharmaceutical Preparations
30%
7-(4-(3-(1H-inden-3-yl)propyl)piperazin-1-yl)-1,3-benzoxazol-2(3H)-one
30%
Sildenafil Citrate
29%
Erectile Dysfunction
29%
Phosphodiesterase Inhibitors
28%
SB-480848
28%
Cyclohexenes
26%
Epoxy Compounds
25%
Hydroxyl Radical
25%
ophiobolins
25%
tropone
25%
Carbamates
24%
ophiobolin A
24%
Enzymes
23%
Schizophrenia
23%
Calcium-Sensing Receptors
23%
N-(2-hydroxy-3-(2-cyano-3-chlorophenoxy)propyl)-1,1-dimethyl-2-(2-nephthyl)ethylamine
22%
Hydroxyquinolines
22%
Amides
21%
Dopamine D2 Receptors
20%
In Vitro Techniques
20%
Enzyme Inhibitors
20%
Dopamine
20%
Choline O-Acetyltransferase
19%
Psychological Inhibition
19%
carbazole
19%
Therapeutics
18%
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
18%
Wuchereria bancrofti
17%
Ligands
17%
Sulfonamides
17%
Histone Demethylases
17%
Esters
17%
Ketones
16%
HSP90 Heat-Shock Proteins
16%
Filarial Elephantiasis
16%
Cyclic AMP-Dependent Protein Kinases
16%
Chemical Compounds
Phosphodiesterase V Inhibitor
55%
Structure-Activity Relationship
47%
(-)-Epigallocatechin
45%
Sildenafil
41%
Agent Interacting With Transmitter, Hormone or Drug Receptor
39%
Hsp90 Inhibitor
37%
Drug
37%
Protein
35%
Parasitic
32%
Gallate
31%
Partial Agonist
30%
Photocyclization
30%
Chemistry
28%
Diastereomer
27%
Diamine
27%
Serotonin
26%
Ophiobolin A
24%
K-252a
23%
Boceprevir
22%
Stereochemistry
22%
Dopamine
22%
Iodolactonization
22%
Antitumor
21%
Disorder
20%
Hydroxyl
19%
Molecule
19%
Ester
19%
Cord
19%
Vinyllithium
19%
Choline
19%
Dipeptidyl Peptidase IV Inhibitor
18%
Dose
18%
EC 3.1.4.* (Phosphoric Diester Hydrolase) Inhibitor
17%
Protein Kinase Inhibitor
17%
Oxirane
17%
Tertiary Amide
16%
Antiviral Drug
16%
Application
15%
Baeyer-Villiger Oxidation
15%
Amino Acid Ester
15%
Dihydrofolates
14%
Ethylamine
14%
Sulfonamide
14%
Neurotoxin
14%
Cyclohexene
13%
Enzyme Inhibitor
13%